CEO, Itzik MizrahiSource: NAI Puget Sound Properties
- Life sciences company eSense-Lab (ESE) has signed an agreement with the Israeli Ministry of Health (MOH) to conduct a joint research project
- The company will test its proprietary TRP-ENV compound against a human coronavirus strain, to assess its antiviral properties
- eSense-Lab will conduct the research at the Central Virology lab within the Chaim Sheba Medical Centre, Israel’s largest hospital
- Final results of the research project should be available by November 2020
- eSense-Lab closed in the grey for 1.8 cents per share